criteria for glp-1 If you're covered by the State Health Benefit Plan (SHBP) and take a weight-loss medication (like Wegovy or Zepbound), a change is coming. Starting February 1, 2026, SHBP will require these GLP-1a: Going beyond Traditional Use

Salvi II Millions of Americans have turned to GLP-1 drugs like Ozempic and Wegovy to manage diabetes and weight, but a growing number of those patients have experienced severe and unexpected health complications

Important caveat: claims that injectable glutathione provides proven skin-lightening, detox, or anti-aging benefits are not supported by adequate evidence

La mayora de nuestras pacientes las programan junto a otra cita o como una visita breve independiente

While GLP-1 medications are generally well-tolerated, some individuals may experience side effects such as nausea, vomiting, or gastrointestinal discomfort